| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. (REGN) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 58 sells. REGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 310.5K | $189.36M | - | |
| CEO | 214.5K | $130.85M | - | |
| VP | 47.8K | $29.18M | - | |
| VP | 29.5K | $18.00M | - | |
| VP | 21.7K | $13.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 | Ryan Arthur F54 | Director | Sell | 100 | $817.30 | $81,729.89 | - | +18.6% | -7.9% | |
| Nov 14, 2023 | Murphy Andrew J54 | EVP Research | Sale+OE | 6,492 | $799.17 | $5,188,213.10 | -0.9% | +19.3% | +1.3% | |
| Nov 7, 2023 | Ryan Arthur F54 | Director | Sell | 100 | $827.90 | $82,789.98 | - | +12.7% | -1.7% | |
| Nov 1, 2023 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,000 | $783.91 | $783,910.00 | -4.8% | +21.3% | +5.9% | |
| Oct 13, 2023 | Zoghbi Huda Y | Director | Sale+OE | 1,000 | $850.00 | $850,000.00 | -44.5% | +9.1% | +21.0% | |
| Oct 2, 2023 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,038 | $827.00 | $858,426.00 | -5.0% | +10.6% | +28.0% | |
| Sep 1, 2023 | McCourt Marion55 | EVP Commercial | Sell | 250 | $834.55 | $208,637.50 | -1.2% | -0.9% | +42.5% | |
| Aug 24, 2023 | Van Plew Daniel P | EVP &General Mgr, Industrial | Sale+OE | 6,197 | $841.71 | $5,216,072.87 | -2.4% | -3.8% | +44.3% | |
| Aug 23, 2023 | Poon Christine A51 | Director | Sale+OE | 12,280 | $839.97 | $10,314,828.70 | -23.7% | -5.0% | +41.3% | |
| Aug 23, 2023 | Landry Robert E52 | EVP Finance CFO | Sell | 223 | $844.00 | $188,212.00 | -0.7% | -5.0% | +41.3% |